Latest work unexpectedly shows two close bat virus relatives of human respiratory virus MERS-CoV use bat ACE2 as cell entry receptor.
Results from a new molecular study provide a framework to guide engineering of future SARS-CoV-2 vaccines.
Understanding antibody responses will be key to offset coronavirus variants' evasion of earlier immunity.
While Omicron variants ratchet up immune evasion, study suggests current boosters intensify protections against serious infection
SKbioscience’s SKYCovione vaccine becomes the first therapeutic OK'd for people to emerge from the Institute for Protein Design.
David Veesler is among 31 finalists for the 2022 Blavatnik Family Foundation National Awards for Young Scientists.
Leading UW Medicine and Fred Hutch scientists in microbiology, biochemistry and genome sciences are among the new members.
Cryoelectron microscopy studies of Nipah and Hendra viruses may lead to ideas for vaccine design and antibody treatments.
Technique allows researchers to toggle on individual genes that regulate cell growth, development and function.
The antibody closely mimics the binding site that the SARS-CoV-2 virus uses to infect cells, and seemingly thwarts invasion via mutation.